Genitourinary paraganglioma: Demographic, pathologic, and clinical characteristics in the surveillance, epidemiology, and end results database (2000-2012).

[1]  M. Persky,et al.  The Multidisciplinary Management of Paragangliomas of the Head and Neck , Part 1 Review , 2017 .

[2]  Hengguo Li,et al.  Bladder Paraganglioma: Clinicopathology and Magnetic Resonance Imaging Study of Five Patients. , 2016, Urology journal.

[3]  D. Pal,et al.  Paraganglioma of urinary bladder , 2015, Urology annals.

[4]  W. Linehan,et al.  Association of urinary bladder paragangliomas with germline mutations in the SDHB and VHL genes. , 2015, Urologic oncology.

[5]  R. Richmond,et al.  Anesthetic management for resection of para-aortic paraganglioma and unexpected aortic resection: A case report , 2015, Experimental and therapeutic medicine.

[6]  M. Ranaweera,et al.  Bladder paraganglioma: A report of case series and critical review of current literature. , 2014, World journal of clinical cases.

[7]  S. Menon,et al.  Paraganglioma of the urinary bladder: a clinicopathologic spectrum of a series of 14 cases emphasizing diagnostic dilemmas. , 2014, Indian journal of pathology & microbiology.

[8]  S. Roman,et al.  Malignant pheochromocytoma and paraganglioma: A population level analysis of long‐term survival over two decades , 2013, Journal of surgical oncology.

[9]  D. Metz,et al.  Consensus guidelines for the management and treatment of neuroendocrine tumors. , 2013, Pancreas.

[10]  J. Hajdenberg,et al.  Pheochromocytoma of the urinary bladder: a systematic review of the contemporary literature , 2013, BMC Urology.

[11]  D. Fraker,et al.  Inherited Mutations in Pheochromocytoma and Paraganglioma: Why All Patients Should Be Offered Genetic Testing , 2013, Annals of Surgical Oncology.

[12]  Hollis G. Potter,et al.  Author Manuscript , 2013 .

[13]  R. Jansen,et al.  Paraganglioma of the bladder. , 2012, Clinical advances in hematology & oncology : H&O.

[14]  A. Martín-Rodríguez,et al.  Paraganglioma of Prostatic Origin , 2012, Clinical Medicine Insights: Case Reports.

[15]  P. Söderkvist,et al.  Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas. , 2011, Endocrine-related cancer.

[16]  C. Vocke,et al.  Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location. , 2011, The Journal of clinical endocrinology and metabolism.

[17]  Herb Chen,et al.  The North American Neuroendocrine Tumor Society Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors: Pheochromocytoma, Paraganglioma, and Medullary Thyroid Cancer , 2010, Pancreas.

[18]  Cary P Gross,et al.  NCI SEER public-use data: applications and limitations in oncology research. , 2009, Oncology.

[19]  Q. Duh,et al.  Sporadic Paraganglioma , 2007, World Journal of Surgery.

[20]  W. Young,et al.  Paragangliomas , 2006, Annals of the New York Academy of Sciences.

[21]  J. M. Giménez-Bachs,et al.  Paraganglioma of the Bladder: Controversy regarding Treatment , 2004, Urologia Internationalis.

[22]  P. Dahm,et al.  Malignant non-urothelial neoplasms of the urinary bladder: a review. , 2003, European urology.

[23]  M. Persky,et al.  The multidisciplinary management of paragangliomas of the head and neck, Part 2. , 2003, Oncology.

[24]  W. Young,et al.  Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. , 2001, The Journal of clinical endocrinology and metabolism.

[25]  J. Cheville,et al.  Paraganglioma of the urinary bladder , 2000, Cancer.

[26]  G. Nesi,et al.  Paraganglioma of the urinary bladder. , 1996, Urologia internationalis.

[27]  A. Cochran,et al.  Paragangliomas: assessment of prognosis by histologic, immunohistochemical, and ultrastructural techniques. , 1989, Human pathology.

[28]  Z. Górko,et al.  [Extra-adrenal pheochromocytoma]. , 1966, Polski tygodnik lekarski.